Health-care companies rose, as traders sought out sectors less likely to be affected by a government shutdown.
Shares of Coherus BioSciences fell after the Food and Drug Administration rejected a biologics license application supplement for certain injections.
Shares of Vaccitech more than doubled after research firm Alliance Global Partners touted the immunotherapy drug developer's prospects for blockbuster drugs.
French pharmaceutical giant Sanofi expects currency movements to hurt its third-quarter sales and business earnings per share, according to preliminary estimates released by the company.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
09-25-23 1804ET
